Cusatuzumab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Cusatuzumab, covering 2024-07-30 to 2025-09-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy [Phase 2]